Raha Samraat S.
President and CEO
Raha Samraat S. has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jun 12, 2026.
On the most recent filing, Raha Samraat S. is listed as President and CEO at MYRIAD GENETICS INC. Inside the rolling window, Raha Samraat S. reported 1 open-market purchase totaling $200K in MYGN and no open-market sales.
Companies traded
Other insiders at MYGN
Insider Buying
$200K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Raha Samraat S. made?
Raha Samraat S. has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Raha Samraat S. trade?
Raha Samraat S. has filed SEC Form 4 disclosures for 1 company, including MYGN.
When was Raha Samraat S.'s most recent SEC Form 4 filing?
Raha Samraat S.'s most recent SEC Form 4 filing on Tracefour is dated Jun 12, 2026.
What is Raha Samraat S.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Raha Samraat S. is listed as President and CEO.
What is Raha Samraat S.'s total buy and sell value in the current window?
Inside the rolling retention window, Raha Samraat S. bought $200K and sold $0 based on SEC Form 4 filings.
What was Raha Samraat S.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 40,000 MYGN shares on 2026-03-09, worth $200K, per SEC Form 4 filings.